Concepedia

Author

Piera Capranzano

University of CataniaORCID

Also Known As

A. M. Caggegi, Capranzano, Piera, Davide Capodanno, P Capranzano, P. Capranzano, Patrizia Presbitero, Piera Capranzano

288

Publications

7.9K

Citations

46

H-Index

68

Concepts

All Affiliations

University of CataniaFerrarotto HospitalSan Raffaele University of RomeA. O. Ordine Mauriziano di TorinoElisabeth-Krankenhaus Essen
PC

About

Piera Capranzano is an author at University of Catania specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

41

2.2K

2

Public Health

10

11

491

3

Engineering

2

2

49

4

Health Sciences

2

2

74

5

Social Sciences

1

1

22

Piera Capranzano

×

88

Publications

5.6K

Citations

38

H-Index

YearCitations

European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection

David Adlam, Fernándo Alfonso, Angela H.E.M. Maas,

European Heart Journal

2018

627

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

Davide Capodanno, Tommaso Gori, Holger Nef,

EuroIntervention

2015

450

Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Guido Parodi, Benedetta Bellandi, Ioanna Xanthopoulou,

Circulation Cardiovascular Interventions

2015

208

A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study

Dominick J. Angiolillo, Piera Capranzano, Shinya Goto,

European Heart Journal

2008

198

Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease

Davide Capodanno, Aasita Patel, Kodlipet Dharmashankar,

Circulation Cardiovascular Interventions

2011

185

Usefulness of SYNTAX Score to Select Patients With Left Main Coronary Artery Disease to Be Treated With Coronary Artery Bypass Graft

Davide Capodanno, Piera Capranzano, M. Salvo,

JACC: Cardiovascular Interventions

2009

177

Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective

Corrado Tamburino, Azeem Latib, Robert‐Jan van Geuns,

EuroIntervention

2015

155

Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry

Yohei Ohno, Guiherme F. Attizzani, Davide Capodanno,

European Heart Journal - Cardiovascular Imaging

2014

150

A Simple Risk Tool (the OBSERVANT Score) for Prediction of 30-Day Mortality After Transcatheter Aortic Valve Replacement

Davide Capodanno, Marco Barbanti, Corrado Tamburino,

The American Journal of Cardiology

2014

148

Global Risk Classification and Clinical SYNTAX (Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery) Score in Patients Undergoing Percutaneous or Surgical Left Main Revascularization

Davide Capodanno, Anna Caggegi, Marco Miano,

JACC: Cardiovascular Interventions

2011

148

Page 1